SAGE Therapeutics Inc at Cowen HealthCare Conference Transcript
Thank you, everyone, for joining us here at the Cowen Health Care Conference and the Sage Therapeutics fireside chat. With us today for the conversation, we have SVP of Clinical Development, Chris Silber; Mike Cloonan, Chief Business Officer; and Kimi Iguchi, CFO. I will turn it over to Kimi for a few opening remarks, and then we'll jump into the Q&A.
Great. Well, thank you, Ritu. Thanks very much for -- we're delighted to be here. Again, my name is Kimi Iguchi. I'm the Chief Financial Officer. And just to start, a little housekeeping, we will be making forward-looking statements. So you can certainly access our SEC filings on our website. But just for those of you who might not be as familiar with Sage, we were -- we're about 9 years old. And when we started, it was really all about brain disorders and thinking about how we can help people with brain disorders. And at the time we've started
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |